Correlation Engine 2.0
Clear Search sequence regions

  • antigens cd19 (3)
  • CD19 antigen (8)
  • CD25 (1)
  • CD69 (1)
  • co culture (1)
  • control group (1)
  • count cells (1)
  • genes (1)
  • humans (1)
  • leukemia (3)
  • plasmid (1)
  • protein t (1)
  • research (1)
  • RFP (1)
  • t lymphocytes (17)
  • tri (2)
  • Sizes of these terms reflect their relevance to your search.

    Objective: To prepare a novel tri-specific T cell engager (19TriTE) targeting CD19 antigen, and to investigate its immunotherapeutic effect on CD19-positive hematological malignancies. Methods: 19TriTE was constructed by molecular cloning technology and successfully expressed through the eukaryotic expressing system. The effects of 19TriTE on the proliferation and activation of T cells, as well as the specific cytotoxicity against CD19 positive tumor cell lines were verified. Results: ①19TriTE expressing plasmid was constructed and successfully expressed through the eukaryotic expressing system. ②19TriTE can specifically bind to T cells and Nalm6 cells, with equilibrium dissociation constants of 19.21 nmol/L and 11.67 nmol/L, respectively. ③The expression rates of CD69 positive T cells and CD25 positive T cells were 35.4% and 49.8% respectively, when 2 nmol/L 19TriTE were added in the co-culture system, which were significantly higher than those in the control group. ④19TriTE can significantly promote the proliferation of T cells. The absolute count of T cells expanded from the initial one million to 74 million with an 74 fold increase at the concentration of 1 nmol/L on day 12. ⑤19TriTE can significantly mediate T cells killing of CD19 positive target cells in a dose-dependent manner. At the concentration of 10 nmol/L, the target cells lysis reached 50%. ⑥Degranulation experiment verified that 19TriTE can activate T cells in the presence of CD19 positive target cells, and the activation of T cells positively correlated with the dose of 19TriTE. ⑦When 19TriTE fusion protein co-cultured with T cells and target cells overexpression RFP and luciferase genes respectively, 19TriTE can notably mediate T cells killing of CD19 positive target cells through fluorescent microscope or bioluminescence imaging technology. Conclusion: In this study, we successfully constructed and expressed 19TriTE fusion protein and verified that it can effectively activate T cells and promote their proliferation in vitro. At the same time, it can bind to CD19 positive target cells and T cells, as well as enhance T cells anti-leukemia effect in vitro, providing the foundation for further clinical research.


    M L Chen, N Peng, X Y Liu, T Zhang, Y X Xu, Z Tian, H Y Xing, K J Tang, Q Rao, J X Wang, M Wang. Preparation of a novel tri-specific T cell engager targeting CD19 antigen and its anti-leukemia effect exploration]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2021 Mar 14;42(3):217-223

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33910307

    View Full Text